REQUEST A DEMO
Total
USD $0.00
Search more companies

Cong Ty Co Phan Duoc Pham Agimexpharm (Vietnam)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Cong Ty Co Phan Duoc Pham Agimexpharm Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company specializes in production of pharmaceuticals, medicinal chemical and botanical products.
The Company was founded in 1981, operates under the business registration certificate number 1600699279 issued by the Department of Planning and Investment An Giang Province on September 20, 2012.
The Company s headquarters is located at 27 Nguyen Thai Hoc Street, My Binh Ward, Long Xuyen City, An Giang Province.
Lines of business:
Manufacture of pharmaceuticals, medicinal and herbal;
Purchase and sale of optical equipment, medical equipment, dental, hospital equipment;
Purchase and sale of drugs, pharmaceuticals;
Buying and selling nutritious foods;
Buying and selling cosmetics, trading raw materials, pharmaceutical manufacturing pharmaceutical service;
Purchase and sale of vaccines and biologicals; bottled water production;
Production of functional foods.
History:
1981: Formerly the An Giang Pharmaceutical Factory was established under decision No. 52/QD.UB issued by People s Committee of An Giang Province on June 10, 1981.
1992: Renamed to An Giang Pharmaceutical Union Factory , abbreviated as ANGIPHARMA.
1996: Renamed to An Giang Pharmaceutical Company under decision No. 82/QD.UB issued by People s Committee of An Giang Province on December 7, 1996.
2003: Renamed to An Giang Pharmaceutical Joint Stock Company under decision No. 2778/QD.UB issued by People s Committee of An Giang Province on December 29, 2003. Business registration certificate No. 5203000020 issued by the Department of Planning and Investment An Giang Province on June 3, 2004.
2008: Renamed to Agimexpharm Pharmaceutical Jiont Stock Company on May 20, 2008
2015: The Company s shares were listed on Hanoi Upcom Securities Trading Center under the symbol AGP

Headquarters
27 Nguyen Thai Hoc, My Binh Ward
Long Xuyen; Mekong River Delta; Postal Code: 88

Contact Details: Purchase the Cong Ty Co Phan Duoc Pham Agimexpharm report to view the information.

Website: http://www.agimexpharm.com

Basic Information
Total Employees:
Purchase the Cong Ty Co Phan Duoc Pham Agimexpharm report to view the information.
Outstanding Shares:
Purchase the Cong Ty Co Phan Duoc Pham Agimexpharm report to view the information.
Financial Auditors:
Purchase the Cong Ty Co Phan Duoc Pham Agimexpharm report to view the information.
Incorporation Date:
1981
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice Chief Executive Officer
Purchase this report to view the information.
Vice Chief Executive Officer
Purchase this report to view the information.
Vice Chief Executive Officer
Ownership Details
Purchase this report to view the information.
31.56%
Purchase this report to view the information.
15.21%
Purchase this report to view the information.
14.45%
Company Performance
Financial values in the chart are available after Cong Ty Co Phan Duoc Pham Agimexpharm report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.
Net sales revenue
5.54%
Total operating revenue
5.54%
Operating profit (EBIT)
14.78%
EBITDA
21.15%
Net Profit (Loss) for the Period
1.64%
Total assets
11.88%
Total equity
12.9%
Operating Profit Margin (ROS)
1.03%
Net Profit Margin
-0.24%
Return on Equity (ROE)
-1.36%
Debt to Equity Ratio
-0.51%
Quick Ratio
-0.01%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?